Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Binder

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Dermatology|April 7, 1999
Relevance of complement fixing antinuclear antibodiesY V Fang, S J Cyran, B Albini, et al.
Reumatismo|November 6, 2010
[Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I]L Andreoli, C Nalli, M Motta, et al.
Reumatismo|July 22, 2011
[Fine specificity of anti-β2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1]C Nalli, L Andreoli, M Motta, et al.
Lupus|February 10, 2011
'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010M L Bertolaccini, O Amengual, T Atsumi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Dermatology|April 7, 1999
Relevance of complement fixing antinuclear antibodiesY V Fang, S J Cyran, B Albini, et al.
Reumatismo|November 6, 2010
[Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I]L Andreoli, C Nalli, M Motta, et al.
Reumatismo|July 22, 2011
[Fine specificity of anti-β2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1]C Nalli, L Andreoli, M Motta, et al.
Lupus|February 10, 2011
'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010M L Bertolaccini, O Amengual, T Atsumi, et al.
Pageof 2